Key Findings

The study reports two novel CTX-M-25-group extended-spectrum beta-lactamase variants, CTX-M-94 and CTX-M-100, identified in Escherichia coli isolates from Israel. These variants differ from existing CTX-M-25 and CTX-M-39 enzymes through specific amino acid substitutions, which contribute to their resistance profiles against β-lactam antibiotics.